M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_43804

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_43804 24 0.49 Mlig455_006767

Neo: -

Age: -

 Mlig455_006767 {REF} {Length: 315} {NoTransDecoderORF} {RNA1509_9393} {RNA1310_740.1} {RNA815_41450}

Cumulative graph for MligTC455_43804

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -5.489 0.965 0.21117 0.85076
RegionR2 4.351 0.965 0.00386 0.05438
RegionR3 1.174 0.965 0.47461 0.97945
RegionR4 -1.571 0.965 1.00000 1.00000
RegionR5 -0.964 0.965 0.99766 1.00000
RegionR6 0.536 0.965 0.78556 1.00000
RegionR7 0.956 0.965 0.57757 1.00000
RegionR8 1.006 0.965 0.67470 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 1.781 0.965 0.99987 1.00000
RegenerationR2 -4.343 0.965 0.00025 0.02053
RegenerationR3 -1.087 0.965 0.23887 0.67305
RegenerationR4 -1.664 0.965 0.10448 0.49845
RegenerationR5 -0.031 0.965 0.57584 0.89843
RegenerationR6 -1.183 0.965 0.22929 0.57499
RegenerationBL 0.36 0.965 0.67175 1.00000
RegenerationTP -2.982 0.965 0.29557 0.74090


Genes with expression patterns similar to MligTC455_43804

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_43804 24 0.49 Mlig455_006767

Neo: -

Age: -

 2 - - 1.000 - 1.000 - Mlig455_006767 {REF} {Length: 315} {NoTransDecoderORF} {RNA1509_9393} {RNA1310_740.1} {RNA815_41450}
2. MligTC455_19466 542 11.28 Mlig455_007916, Mlig455_008023

Neo: -

Age: -

 1.706 - - 0.748 - 0.958 -

Mlig455_007916 {REF} {Length: 1335} {RNA1509_32168} {RNA1310_48781} {RNA815_25983}

Mlig455_008023 {REF} {Length: 1864} {RNA1509_32168} {RNA1310_48781} {RNA815_25983}
3. MligTC455_14598 52 1.07 Mlig455_058970

Neo: -

Age: -

 0.987 - - 0.987 - - - Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309}
4. MligTC455_45021 381 7.95 Mlig455_046686

Neo: -

Age: Down-Up-Up

Region-enriched R2: 3.428/0.03156

 AVP 0.987 - - 0.987 - - - Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813}
5. MligTC455_14317 18 0.37 Mlig455_032329

Neo: -

Age: -

Region-enriched R2: 9.341/0.00123
Region-enriched R3: 4.750/0.03053
Region-enriched R5: 3.394/0.03262

 0.985 - - 0.985 - - - Mlig455_032329 {REF} {Length: 1038} {RNA1509_48973} {RNA1310_34931} {RNA815_36286}
6. MligTC455_45020 386 8.05 Mlig455_012422

Neo: -

Age: -

Region-enriched R2: 4.067/0.00066
Region-enriched R3: 2.869/0.01291

 AVP 0.984 - - 0.984 - - - Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813}
7. MligTC455_26486 23 0.48 Mlig455_061161

Neo: -

Age: -

 0.983 - - 0.983 - - - Mlig455_061161 {REF} {Length: 903} {RNA1310_57274} {RNA815_36012}
8. MligTC455_24271 22 0.45 Mlig455_005190

Neo: -

Age: -

 0.982 - - 0.982 - - - Mlig455_005190 {REF} {Length: 600} {RNA1509_43533} {RNA1310_100097} {RNA815_22406}
9. MligTC455_15949 37 0.76 Mlig455_059880

Neo: -

Age: -

 0.98 - - 0.980 - - - Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903}
10. MligTC455_22323 68 1.42 Mlig455_000713, Mlig455_000766

Neo: -

Age: -

 HCN4 0.977 - - 0.977 - - -

Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1}

Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1}
11. MligTC455_22428 96 2.01 Mlig455_011005

Neo: -

Age: -

 0.976 - - 0.976 - - - Mlig455_011005 {REF} {Length: 3873} {Pfam: WS/DGAT C-terminal domain [PF06974.15, score=54.7]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=22.2]; Telomere-associated protein TERB2 [PF15101.8, score=20.0]; ZIP Zinc transporter [PF02535.24, score=18.7]; Ureide permease [PF07168.13, score=17.4]} {Smed: dd_Smed_v6_7004_0_1, dd_Smed_v6_7004_0_1, [Score=151, Expect=2e-37]} {RNA1310_98904}
12. MligTC455_43390 28 0.59 Mlig455_064273

Neo: -

Age: Down-Up-Down

 PRKAR2A 0.976 - - 0.976 - - - Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628}
13. MligTC455_18909 14 0.29 Mlig455_033525

Neo: -

Age: -

 0.974 - - 0.974 - - - Mlig455_033525 {REF} {Length: 1169} {RNA1310_56722} {RNA815_26444}
14. MligTC455_26989 89 1.86 Mlig455_034742

Neo: -

Age: Up-Down-Up

Region-enriched R2: 3.365/0.02989

 MARCO 0.974 - - 0.974 - - - Mlig455_034742 {REF} {Length: 6878} {Human: ENSG00000019169, MARCO, macrophage receptor with collagenous structure, [Score=58.2, Expect=2e-08]; ENSG00000142173, COL6A2, collagen type VI alpha 2 chain, [Score=57.0, Expect=6e-08]; ENSG00000100285, NEFH, neurofilament heavy, [Score=56.6, Expect=7e-08]} {Mouse: ENSMUSG00000020396, Nefh, neurofilament, heavy polypeptide, [Score=102, Expect=1e-22]} {Dmel: FBgn0013733, shot, short stop, [Score=55.1, Expect=1e-07]} {Smed: dd_Smed_v6_8075_0_1, dd_Smed_v6_8075_0_1, [Score=60.1, Expect=2e-09]} {RNA1509_53835} {RNA1310_34822} {RNA815_27277}
15. MligTC455_14085 29 0.61 Mlig455_002893

Neo: -

Age: Up-Down-Down

Region-enriched R2: 6.406/0.01193

 PPP2R5D 0.972 - - 0.972 - - - Mlig455_002893 {REF} {Length: 4141} {Pfam: Protein phosphatase 2A regulatory B subunit (B56 family) [PF01603.22, score=580.3]} {Human: ENSG00000112640, PPP2R5D, protein phosphatase 2 regulatory subunit B'delta, [RH, Score=675, Expect=0.0]; ENSG00000078304, PPP2R5C, protein phosphatase 2 regulatory subunit B'gamma, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000059409, Ppp2r5d, protein phosphatase 2, regulatory subunit B', delta, [RH, Score=677, Expect=0.0]; ENSMUSG00000017843, Ppp2r5c, protein phosphatase 2, regulatory subunit B', gamma, [RH, Score=645, Expect=0.0]} {Dmel: FBgn0042693, wrd, well-rounded, [RH, Score=654, Expect=0.0]} {Celegans: WBGene00007554, pptr-2, Protein Phosphatase 2A (Two A) Regulatory subunit, [RH, Score=638, Expect=0.0]} {Smed: dd_Smed_v6_3379_0_1, dd_Smed_v6_3379_0_1, [RH, Score=665, Expect=0.0]} {RNA1509_7339} {RNA1310_39381} {RNA815_26062}
16. MligTC455_17218 37 0.78 Mlig455_053853

Neo: -

Age: -

 0.972 - - 0.972 - - - Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921}
17. MligTC455_52476 268 5.59 Mlig455_033984

Neo: -

Age: logFC(26M/2M)=-0.811

 ANKFY1 0.972 - - - - 0.972 - Mlig455_033984 {REF} {Length: 4276} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=243.6]; Ankyrin repeats (many copies) [PF13637.8, score=201.1]; Ankyrin repeat [PF13606.8, score=175.3]; Ankyrin repeats (many copies) [PF13857.8, score=175.0]; Ankyrin repeat [PF00023.32, score=173.9]; FYVE zinc finger [PF01363.23, score=50.6]; BTB/POZ domain [PF00651.33, score=31.9]} {Human: ENSG00000185722, ANKFY1, ankyrin repeat and FYVE domain containing 1, [RH, Score=847, Expect=0.0]} {Mouse: ENSMUSG00000020790, Ankfy1, ankyrin repeat and FYVE domain containing 1, [RH, Score=854, Expect=0.0]} {Dmel: FBgn0039955, CG41099, [RH, Score=674, Expect=0.0]} {Celegans: WBGene00009064, F22G12.4, [RH, Score=382, Expect=1e-114]} {Smed: dd_Smed_v6_13446_0_1, dd_Smed_v6_13446_0_1, [RH, Score=371, Expect=3e-109]} {RNA1509_32776, RNA1509_6101} {RNA1310_2689, RNA1509_32776} {RNA1509_32776, RNA815_673}
18. MligTC455_00623 61 1.26 Mlig455_008443

Neo: -

Age: -

 0.971 - - 0.971 - - - Mlig455_008443 {REF} {Length: 513} {Dmel: FBgn0029807, CG3108, [Score=52.0, Expect=5e-08]} {RNA815_25060}
19. MligTC455_16054 25 0.52 Mlig455_031933

Neo: -

Age: -

 0.97 - - 0.970 - - - Mlig455_031933 {REF} {Length: 666} {RNA1310_71129.1} {RNA815_34113}
20. MligTC455_48064 23 0.48 Mlig455_061550

Neo: -

Age: -

 0.97 - - 0.970 - - - Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885}
21. MligTC455_12183 53 1.11 Mlig455_004166, Mlig455_004190

Neo: -

Age: -

Region-enriched R2: 4.930/0.01881

 0.969 - - 0.969 - - -

Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453}

Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453}
22. MligTC455_16233 307 6.4 Mlig455_011368

Neo: -

Age: logFC(26M/2M)=-1.958

 0.969 - - 0.969 - - - Mlig455_011368 {REF} {Length: 1236} {RNA1509_44264} {RNA1310_62516} {RNA815_23574}
23. MligTC455_45910 20 0.42 Mlig455_068873

Neo: -

Age: -

 ANGPT4 0.969 - - 0.969 - - - Mlig455_068873 {REF} {Length: 1013} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=111.7]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=95.1, Expect=7e-22]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=91.3, Expect=2e-20]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=93.6, Expect=3e-22]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=93.2, Expect=1e-21]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=90.9, Expect=1e-20]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=89.4, Expect=4e-20]} {Dmel: FBgn0087011, CG41520, [Score=87.0, Expect=2e-19]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=105, Expect=7e-26]} {RNA1310_32728} {RNA815_23388}
24. MligTC455_16208 38 0.8 Mlig455_060360

Neo: -

Age: -

 FCN2 0.967 - - 0.967 - - - Mlig455_060360 {REF} {Length: 1127} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=136.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=118, Expect=7e-31]; ENSG00000085265, FCN1, ficolin 1, [Score=117, Expect=3e-30]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=116, Expect=6e-30]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=111, Expect=5e-27]} {Dmel: FBgn0034160, CG5550, [Score=109, Expect=6e-28]} {Celegans: WBGene00020516, T15B7.1, [Score=52.4, Expect=1e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=96.3, Expect=5e-22]} {RNA1310_68891}
25. MligTC455_17018 93 1.93 Mlig455_008015

Neo: -

Age: logFC(26M/2M)=1.300

 0.967 - - 0.967 - - - Mlig455_008015 {REF} {Length: 1919} {TRANSSPLICED} {Pfam: Sleepless protein [PF17064.7, score=37.0]} {Dmel: FBgn0260499, qvr, quiver, [Score=69.7, Expect=2e-15]} {Smed: dd_Smed_v6_16907_0_2, dd_Smed_v6_16907_0_2, [Score=74.7, Expect=1e-17]} {RNA1310_61248} {RNA815_27518}
26. MligTC455_38682 102 2.12 Mlig455_039641

Neo: -

Age: -

Region-enriched R2: 6.138/0.02363

 SLC18A3 0.967 - - 0.967 - - - Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1}
27. MligTC455_42376 61 1.27 Mlig455_069890

Neo: -

Age: -

 0.967 - - 0.967 - - - Mlig455_069890 {REF} {Length: 630} {TRANSSPLICED} {Pfam: PAN domain [PF00024.28, score=26.1]} {RNA1509_53783} {RNA1310_37190} {RNA815_24434}
28. MligTC455_42645 144 3 Mlig455_012431

Neo: -

Age: -

 KRT8 0.967 - - 0.967 - - - Mlig455_012431 {REF} {Length: 3911} {Pfam: Intermediate filament protein [PF00038.23, score=141.4]; BRE1 E3 ubiquitin ligase [PF08647.13, score=19.8]; Protein of unknown function (DUF3450) [PF11932.10, score=18.3]} {Human: ENSG00000170421, KRT8, keratin 8, [RH, Score=109, Expect=9e-25]; ENSG00000185640, KRT79, keratin 79, [RH, Score=105, Expect=2e-23]} {Mouse: ENSMUSG00000063661, Krt73, keratin 73, [RH, Score=104, Expect=2e-23]} {Dmel: FBgn0010397, LamC, Lamin C, [Score=138, Expect=2e-34]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [Score=246, Expect=3e-74]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [Score=271, Expect=9e-84]} {RNA1310_10400} {RNA815_12264}
29. MligTC455_51179 75 1.55 Mlig455_068660

Neo: -

Age: -

 WEE2 0.966 - - 0.966 - - - Mlig455_068660 {REF} {Length: 3046} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=86.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.7]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.4]} {Human: ENSG00000263042, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]; ENSG00000214102, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]} {Mouse: ENSMUSG00000037159, Wee2, WEE1 homolog 2 (S. pombe), [Score=102, Expect=2e-22]} {Dmel: FBgn0040298, Myt1, [Score=82.0, Expect=6e-16]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_17244_0_1, dd_Smed_v6_17244_0_1, [Score=73.9, Expect=1e-13]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366}
30. MligTC455_10299 72 1.51 Mlig455_023028, Mlig455_023125, Mlig455_023183

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.617

Region-enriched R2: 4.572/0.04281

 ANGPTL1 0.965 - - 0.965 - - -

Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568}

Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568}

Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568}
31. MligTC455_22469 37 0.77 Mlig455_052705

Neo: -

Age: logFC(26M/2M)=-1.003

 GUK1 0.965 - - 0.965 - - - Mlig455_052705 {REF} {Length: 1833} {Pfam: Guanylate kinase [PF00625.23, score=207.7]; AAA domain [PF13671.8, score=35.1]; 50S ribosome-binding GTPase [PF01926.25, score=28.4]; AAA domain [PF13238.8, score=26.9]; ABC transporter [PF00005.29, score=24.3]; AAA ATPase domain [PF13191.8, score=24.0]; AAA domain [PF13401.8, score=23.0]; P-loop containing region of AAA domain [PF13555.8, score=21.3]; RsgA GTPase [PF03193.18, score=20.4]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=19.0]} {Human: ENSG00000143774, GUK1, guanylate kinase 1, [RH, Score=230, Expect=4e-77]} {Mouse: ENSMUSG00000020444, Guk1, guanylate kinase 1, [RH, Score=228, Expect=2e-76]} {Dmel: FBgn0036099, CG11811, [RH, Score=202, Expect=9e-66]} {Celegans: WBGene00020190, guk-1, GUanylate Kinase, [RH, Score=195, Expect=2e-63]} {Smed: dd_Smed_v6_4875_0_1, dd_Smed_v6_4875_0_1, [RH, Score=225, Expect=2e-75]} {RNA1509_30404} {RNA1310_39734} {RNA815_22943.1}
32. MligTC455_46823 69 1.44 Mlig455_040455, Mlig455_042847

Neo: -

Age: -

Region-enriched R2: 5.281/0.02950

 ANGPTL2 0.965 - - 0.965 - - -

Mlig455_040455 {REF} {Length: 1444} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=152.3]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=129, Expect=8e-34]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=129, Expect=9e-34]; ENSG00000085265, FCN1, ficolin 1, [Score=128, Expect=1e-34]; ENSG00000160339, FCN2, ficolin 2, [Score=125, Expect=1e-33]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=129, Expect=6e-34]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=127, Expect=3e-33]} {Dmel: FBgn0033312, CG8642, [Score=117, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=55.1, Expect=2e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=111, Expect=2e-27]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3}

Mlig455_042847 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=154.0]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=7e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=132, Expect=1e-34]; ENSG00000085265, FCN1, ficolin 1, [Score=130, Expect=2e-35]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=126, Expect=1e-32]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=136, Expect=2e-36]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=132, Expect=5e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=130, Expect=1e-34]} {Dmel: FBgn0033312, CG8642, [Score=117, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=57.4, Expect=3e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=114, Expect=2e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3}
33. MligTC455_41226 44 0.92 Mlig455_019357, Mlig455_059122

Neo: -

Age: -

 GALNT1 0.964 - - 0.964 - - -

Mlig455_019357 {REF} {Length: 1606} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=97.5]; Glycosyltransferase like family 2 [PF13641.8, score=38.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.1]; Glycosyltransferase like family 2 [PF10111.11, score=18.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=318, Expect=2e-103]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=311, Expect=4e-100]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=305, Expect=3e-98]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=305, Expect=3e-98]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=316, Expect=1e-102]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=308, Expect=9e-99]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=302, Expect=3e-97]} {Dmel: FBgn0050463, CG30463, [Score=345, Expect=5e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=350, Expect=3e-115]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=353, Expect=1e-117]} {RNA1310_25598} {RNA815_36943}

Mlig455_059122 {REF} {Length: 2150} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=96.4]; Glycosyltransferase like family 2 [PF13641.8, score=35.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=313, Expect=2e-101]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=307, Expect=2e-98]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=300, Expect=6e-96]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=299, Expect=7e-96]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=1e-95]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=311, Expect=1e-100]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=305, Expect=1e-97]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=8e-96]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=296, Expect=5e-94]; ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=296, Expect=2e-91]} {Dmel: FBgn0050463, CG30463, [Score=340, Expect=3e-111]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=344, Expect=3e-113]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=350, Expect=3e-116]} {RNA1310_25598} {RNA815_36943}
34. MligTC455_13095 40 0.82 Mlig455_036239

Neo: -

Age: -

 0.963 - - 0.963 - - - Mlig455_036239 {REF} {Length: 2786} {RNA1509_41201} {RNA1310_51044} {RNA815_51130}
35. MligTC455_17473 91 1.9 Mlig455_024742

Neo: -

Age: Up-Down-Up

Region-enriched R6: 4.336/0.01880

 0.963 - - 0.963 - - - Mlig455_024742 {REF} {Length: 1023} {RNA1509_53854} {RNA1310_31915} {RNA815_45583}
36. MligTC455_43715 48 0.99 Mlig455_034191

Neo: -

Age: Down-Up-Down

Region-enriched R2: 7.969/0.00817

 0.963 - - 0.963 - - - Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250}
37. MligTC455_12511 68 1.42 Mlig455_017662

Neo: -

Age: -

 0.962 - - 0.962 - - - Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171}
38. MligTC455_18891 275 5.73 Mlig455_024941

Neo: -

Age: -

Region-enriched R2: 2.016/0.02450

 0.962 - - 0.962 - - - Mlig455_024941 {REF} {Length: 394} {NoTransDecoderORF} {RNA1509_45136} {RNA1310_56753} {RNA815_28269}
39. MligTC455_18535 29 0.61 Mlig455_035051

Neo: -

Age: -

 0.961 - - 0.961 - - - Mlig455_035051 {REF} {Length: 1809} {RNA1310_97662}
40. MligTC455_21275 158 3.28 Mlig455_015404, Mlig455_015457

Neo: -

Age: -

 MAOA 0.96 - - 0.960 - - -

Mlig455_015404 {REF} {Length: 2767} {Pfam: Flavin containing amine oxidoreductase [PF01593.26, score=176.3]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=41.1]; Thi4 family [PF01946.19, score=28.8]; FAD dependent oxidoreductase [PF01266.26, score=27.6]; FAD binding domain [PF00890.26, score=22.9]; Lycopene cyclase protein [PF05834.14, score=22.4]; FAD dependent oxidoreductase [PF12831.9, score=20.2]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.3]} {Human: ENSG00000189221, MAOA, monoamine oxidase A, [Score=170, Expect=1e-46]} {Mouse: ENSMUSG00000025037, Maoa, monoamine oxidase A, [Score=177, Expect=3e-49]} {Dmel: FBgn0002036, CG10561, [Score=52.8, Expect=4e-07]} {Celegans: WBGene00000138, amx-2, AMine oXidase family, [RH, Score=95.1, Expect=2e-20]} {Smed: dd_Smed_v6_7098_0_2, dd_Smed_v6_7098_0_2, [Score=232, Expect=1e-70]} {RNA1509_33182} {RNA1310_15440} {RNA815_6572}

Mlig455_015457 {REF} {Length: 2767} {Pfam: Flavin containing amine oxidoreductase [PF01593.26, score=176.3]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=41.1]; Thi4 family [PF01946.19, score=28.8]; FAD dependent oxidoreductase [PF01266.26, score=27.6]; FAD binding domain [PF00890.26, score=22.9]; Lycopene cyclase protein [PF05834.14, score=22.4]; FAD dependent oxidoreductase [PF12831.9, score=20.2]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.3]} {Human: ENSG00000189221, MAOA, monoamine oxidase A, [Score=170, Expect=1e-46]} {Mouse: ENSMUSG00000025037, Maoa, monoamine oxidase A, [Score=177, Expect=3e-49]} {Dmel: FBgn0002036, CG10561, [Score=52.8, Expect=4e-07]} {Celegans: WBGene00000138, amx-2, AMine oXidase family, [RH, Score=95.1, Expect=2e-20]} {Smed: dd_Smed_v6_7098_0_2, dd_Smed_v6_7098_0_2, [Score=232, Expect=1e-70]} {RNA1509_33182} {RNA1310_15440} {RNA815_6572}
41. MligTC455_42840 147 3.06 Mlig455_003645

Neo: -

Age: -

 0.96 - - 0.960 - - - Mlig455_003645 {REF} {Length: 1270} {RNA1509_48973} {RNA1310_36721} {RNA815_36286}
42. MligTC455_47780 214 4.46 Mlig455_018842, Mlig455_018853

Neo: -

Age: -

 0.96 - - 0.960 - - -

Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082}

Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082}
43. MligTC455_11314 22 0.45 Mlig455_008025

Neo: -

Age: -

 TRPC5 0.959 - - 0.959 - - - Mlig455_008025 {REF} {Length: 3829} {Pfam: Transient receptor ion channel II [PF08344.13, score=100.2]; Ion transport protein [PF00520.33, score=93.1]; Polycystin cation channel [PF08016.14, score=32.4]; Ankyrin repeats (3 copies) [PF12796.9, score=30.9]; Ankyrin repeat [PF13606.8, score=23.9]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [Score=632, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [Score=615, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [Score=634, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [Score=615, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=598, Expect=0.0]} {Celegans: WBGene00006614, trp-1, Transient-receptor-potential-like protein, [RH, Score=820, Expect=0.0]} {Smed: dd_Smed_v6_15627_0_1, dd_Smed_v6_15627_0_1, [Score=559, Expect=0.0]} {RNA1310_93280} {RNA815_44973}
44. MligTC455_29050 162 3.38 Mlig455_004578

Neo: -

Age: -

 TMEM30A 0.959 - - 0.959 - - - Mlig455_004578 {REF} {Length: 3215} {TRANSSPLICED} {Pfam: LEM3 (ligand-effect modulator 3) family / CDC50 family [PF03381.17, score=266.2]} {Human: ENSG00000112697, TMEM30A, transmembrane protein 30A, [Score=210, Expect=3e-64]} {Mouse: ENSMUSG00000032328, Tmem30a, transmembrane protein 30A, [Score=214, Expect=4e-66]} {Dmel: FBgn0030752, CG9947, [Score=253, Expect=1e-81]} {Celegans: WBGene00019946, chat-1, CDC50 family protein chat-1, [Score=218, Expect=8e-68]} {Smed: dd_Smed_v6_6430_0_1, dd_Smed_v6_6430_0_1, [Score=258, Expect=9e-84]} {RNA1509_38539} {RNA1310_9371} {RNA815_12157}
45. MligTC455_10082 430 8.96 Mlig455_000403, Mlig455_000471

Neo: -

Age: -

Region-enriched R2: 2.917/0.00040

 0.958 - - 0.958 - - -

Mlig455_000403 {REF} {Length: 747} {RNA1310_48386} {RNA815_37422}

Mlig455_000471 {REF} {Length: 750} {RNA1310_48386} {RNA815_37422}
46. MligTC455_15727 112 2.33 Mlig455_027846, Mlig455_060005

Neo: -

Age: -

 0.958 - - 0.958 - - -

Mlig455_027846 {REF} {Length: 910} {Smed: dd_Smed_v6_31751_0_1, dd_Smed_v6_31751_0_1, [RH, Score=47.4, Expect=5e-07]} {RNA1509_36923} {RNA1310_38586} {RNA815_19219}

Mlig455_060005 {REF} {Length: 991} {RNA1509_36923} {RNA1310_38586} {RNA815_19219}
47. MligTC455_31164 572 11.91 Mlig455_029609, Mlig455_045673

Neo: -

Age: -

 0.958 - - 0.958 - - -

Mlig455_029609 {REF} {Length: 746} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=39.4]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=48.5, Expect=1e-06]} {RNA1310_96354} {RNA815_44390}

Mlig455_045673 {REF} {Length: 2025} {RNA1509_21720} {RNA1310_14760} {RNA815_24583}
48. MligTC455_32119 47 0.97 Mlig455_039471

Neo: Int S/G2/M

Age: logFC(26M/2M)=0.687

Region-enriched R5: 3.221/0.01590

 UROS 0.958 - - - - 0.958 - Mlig455_039471 {REF} {Length: 895} {TRANSSPLICED} {Pfam: Uroporphyrinogen-III synthase HemD [PF02602.17, score=86.9]} {Human: ENSG00000188690, UROS, uroporphyrinogen III synthase, [RH, Score=53.1, Expect=1e-07]} {Mouse: ENSMUSG00000030979, Uros, uroporphyrinogen III synthase, [RH, Score=61.6, Expect=7e-11]} {Dmel: FBgn0030066, CG1885, [RH, Score=56.6, Expect=3e-09]} {Smed: dd_Smed_v6_4258_0_1, dd_Smed_v6_4258_0_1, [RH, Score=89.7, Expect=2e-21]} {RNA1509_45687} {RNA1310_11948.2} {RNA815_1561}
49. MligTC455_51178 190 3.97 Mlig455_066114

Neo: -

Age: -

 0.958 - - 0.958 - - - Mlig455_066114 {REF} {Length: 2408} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=58.5, Expect=4e-10]} {RNA1509_36492} {RNA1310_14560, RNA1509_36492} {RNA1509_36492, RNA815_5366}
50. MligTC455_09987 213 4.43 Mlig455_061259

Neo: -

Age: -

 0.957 - - 0.957 - - - Mlig455_061259 {REF} {Length: 878} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF14719.8, score=36.3]} {RNA1509_35099} {RNA1310_42966} {RNA815_24864}
51. MligTC455_44810 226 4.72 Mlig455_013293, Mlig455_035940, Mlig455_058406, Mlig455_058409

Neo: -

Age: -

Region-specific R2: 6.204

Region-enriched R2: 5.509/0.00501

 0.957 - - 0.957 - - -

Mlig455_013293 {REF} {Length: 1362} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=56.6, Expect=2e-09]} {RNA1310_28961.1} {RNA815_27532}

Mlig455_035940 {REF} {Length: 1652} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532}

Mlig455_058406 {REF} {Length: 991} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=4e-09]} {RNA1310_28961.1} {RNA815_27532}

Mlig455_058409 {REF} {Length: 1311} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532}
52. MligTC455_10953 148 3.08 Mlig455_060864, Mlig455_063528

Neo: -

Age: Up-Down-Down

Region-enriched R2: 4.497/0.01237
Region-enriched R5: 3.064/0.03185

 KCNH7 0.956 - - 0.956 - - -

Mlig455_060864 {REF} {Length: 7144} {Pfam: Ion transport protein [PF00520.33, score=117.5]; Cyclic nucleotide-binding domain [PF00027.31, score=52.7]; Ion channel [PF07885.18, score=45.4]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=777, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=760, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=751, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=776, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=761, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=751, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=712, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=798, Expect=0.0]} {RNA1509_40124} {RNA1310_4074} {RNA815_8044}

Mlig455_063528 {REF} {Length: 734} {NoTransDecoderORF}
53. MligTC455_33554 32 0.66 Mlig455_005753

Neo: -

Age: -

 0.956 - - 0.956 - - - Mlig455_005753 {REF} {Length: 2626} {RNA1509_48505} {RNA1310_62885} {RNA815_39881}
54. MligTC455_41540 190 3.96 Mlig455_060056

Neo: -

Age: -

Region-enriched R2: 6.605/0.00196

 GLUL 0.956 - - 0.956 - - - Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6}
55. MligTC455_43488 21 0.43 Mlig455_056742

Neo: -

Age: -

 0.956 - - 0.956 - - - Mlig455_056742 {REF} {Length: 882} {Pfam: WSC domain [PF01822.21, score=53.2]; PAN domain [PF00024.28, score=28.9]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=7e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=54.3, Expect=3e-08]} {RNA1310_48783} {RNA815_22910}
56. MligTC455_37270 86 1.79 Mlig455_022293

Neo: -

Age: -

 CASP3 0.955 - - 0.955 - - - Mlig455_022293 {REF} {Length: 2773} {Pfam: Caspase domain [PF00656.24, score=93.1]; Ankyrin repeats (3 copies) [PF12796.9, score=77.8]; Ankyrin repeats (many copies) [PF13857.8, score=62.2]; Ankyrin repeats (many copies) [PF13637.8, score=56.0]; Ankyrin repeat [PF13606.8, score=39.1]; Ankyrin repeat [PF00023.32, score=28.2]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=109, Expect=7e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]; ENSG00000165806, CASP7, caspase 7, [Score=104, Expect=2e-23]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=9e-25]; ENSMUSG00000031628, Casp3, caspase 3, [Score=103, Expect=3e-24]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=3e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_3121_1_1, dd_Smed_v6_3121_1_1, [Score=102, Expect=3e-24]} {RNA1509_54818} {RNA1310_7187, RNA1509_54818} {RNA1509_54818, RNA815_8712}
57. MligTC455_10083 397 8.27 Mlig455_000410, Mlig455_000477

Neo: -

Age: logFC(26M/2M)=1.533

Region-enriched R2: 3.033/0.00070

 0.954 - - 0.954 - - -

Mlig455_000410 {REF} {Length: 1205} {RNA1509_50537} {RNA1310_48386} {RNA815_37422}

Mlig455_000477 {REF} {Length: 1206} {RNA1509_50537} {RNA1310_48386} {RNA815_37422}
58. MligTC455_17562 108 2.25 Mlig455_022496

Neo: -

Age: -

 NECAB3 0.954 - - 0.954 - - - Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216}
59. MligTC455_23314 139 2.9 Mlig455_039680

Neo: -

Age: -

 CACNA2D2 0.954 - - 0.954 - - - Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071}
60. MligTC455_24270 71 1.47 Mlig455_005120

Neo: -

Age: -

 CHRNA7 0.954 - - 0.954 - - - Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406}
61. MligTC455_53681 335 6.99 Mlig455_064921

Neo: -

Age: -

Region-enriched R2: 6.469/0.00000

 0.954 - - 0.954 - - - Mlig455_064921 {REF} {Length: 1504} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_33258} {RNA815_17150}
62. MligTC455_19228 8 0.18 Mlig455_018525

Neo: -

Age: -

 0.952 - - - - 0.952 - Mlig455_018525 {REF} {Length: 1714} {NoTransDecoderORF} {RNA1310_84835} {RNA815_8235}
63. MligTC455_29012 227 4.74 Mlig455_004572

Neo: -

Age: Down-Down-Up

 TMEM30A 0.952 - - 0.952 - - - Mlig455_004572 {REF} {Length: 3160} {TRANSSPLICED} {Pfam: LEM3 (ligand-effect modulator 3) family / CDC50 family [PF03381.17, score=265.5]} {Human: ENSG00000112697, TMEM30A, transmembrane protein 30A, [RH, Score=234, Expect=7e-73]} {Mouse: ENSMUSG00000032328, Tmem30a, transmembrane protein 30A, [RH, Score=241, Expect=7e-76]} {Dmel: FBgn0030752, CG9947, [RH, Score=294, Expect=9e-97]} {Celegans: WBGene00019946, chat-1, CDC50 family protein chat-1, [Score=246, Expect=3e-78]} {Smed: dd_Smed_v6_6430_0_1, dd_Smed_v6_6430_0_1, [Score=275, Expect=2e-89]} {RNA1509_38539} {RNA1310_9371} {RNA815_12157}
64. MligTC455_40852 128 2.66 Mlig455_042301

Neo: -

Age: Up-Up-Down, logFC(26M/2M)=0.671

Region-enriched R2: 6.158/0.00357

 PKDREJ 0.952 - - 0.952 - - - Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216}
65. MligTC455_51177 76 1.59 Mlig455_058323

Neo: -

Age: Down-Up-Up

 SAXO1 0.952 - - 0.952 - - - Mlig455_058323 {REF} {Length: 1875} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.1, Expect=1e-05]} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=60.8, Expect=5e-11]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366}
66. MligTC455_53720 144 2.99 Mlig455_028516

Neo: -

Age: -

Region-enriched R2: 4.205/0.01762

 CTBP2 0.952 - - 0.952 - - - Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484}
67. MligTC455_02149 10 0.21 Mlig455_070095

Neo: -

Age: -

 0.951 - - 0.951 - - - Mlig455_070095 {REF} {Length: 1351} {RNA1509_31500} {RNA1310_687} {RNA815_17285}
68. MligTC455_35862 39 0.82 Mlig455_025750

Neo: -

Age: -

 0.951 - - 0.951 - - - Mlig455_025750 {REF} {Length: 4430} {Pfam: Interferon-related protein conserved region [PF04836.14, score=35.0]} {RNA1509_56926} {RNA1310_49079} {RNA815_25175.1}
69. MligTC455_19079 218 4.54 Mlig455_008746, Mlig455_008760

Neo: -

Age: Down-Up-Up

Region-specific R2: 6.705

Region-enriched R2: 6.864/0.00152

 0.95 - - 0.950 - - -

Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524}

Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524}
70. MligTC455_52393 60 1.25 Mlig455_039640

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=-0.560

Region-enriched R2: 5.399/0.01138

 CHAT 0.95 - - 0.950 - - - Mlig455_039640 {REF} {Length: 3681} {TRANSSPLICED} {Pfam: Choline/Carnitine o-acyltransferase [PF00755.22, score=546.9]} {Human: ENSG00000070748, CHAT, choline O-acetyltransferase, [RH, Score=520, Expect=1e-176]} {Mouse: ENSMUSG00000021919, Chat, choline acetyltransferase, [RH, Score=521, Expect=3e-177]} {Dmel: FBgn0000303, ChAT, Choline acetyltransferase, [Score=452, Expect=1e-149]} {Celegans: WBGene00000481, cha-1, Choline O-acetyltransferase, [RH, Score=356, Expect=1e-113]} {Smed: dd_Smed_v6_6208_0_1, dd_Smed_v6_6208_0_1, [Score=535, Expect=0.0]} {RNA1509_40088} {RNA1310_20833} {RNA815_26395}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA